Caladrius Biosciences

Total Awards: 
2
Award Value: 
$11,175,946
Institution type: 
For profit
Short Name: 
Caladrius Biosciences
  • Share
  • Print
  • PDF version

Awards to the Institution

Program Investigator Award Title Award Value
Clinical Trial Stage Projects Robert Dillman Tumor stem cell-targeted immunotherapy for metastatic melanoma –a randomized phase 3 clinical trial. $3,000,000
Clinical Trial Stage Projects William Sietsema Phase 2 Safety and Efficacy Study of CLBS03 Autologous T-Regulatory Cells in Adolescents with Recent Onset Type 1 Diabetes Mellitus $8,175,946
Total:
$11,175,946.00
Icon for XLSX export